Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2018: 156.09

Open Access
See all formats and pricing
More options …
Volume 7, Issue 3


Volume 10 (2015)

Survival of patients with head and neck squamous cell carcinoma in association with human papillomavirus and p53 polymorphism

Zivile Gudleviciene / Giedre Smailyte
Published Online: 2012-03-29 | DOI: https://doi.org/10.2478/s11536-011-0148-4
  • [1] Popescu CR, Bertesteanu SVG, Mirea D, Grigore R, Ionescu D, Popescu B. The epidemiology of hypopharynx and cervical esophagus cancer. J Med Life 2010;3(4): 396–401 Google Scholar

  • [2] Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, Kouloulias V. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 2011;3:2 http://dx.doi.org/10.1186/1758-3284-3-2Web of ScienceCrossrefGoogle Scholar

  • [3] Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998;18:4779–4786 Google Scholar

  • [4] Franceschi S, Bidoli E, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000;36:106–115 http://dx.doi.org/10.1016/S1368-8375(99)00070-6CrossrefGoogle Scholar

  • [5] Garrote LF, Herrero R, Reyes RM, Vaccarella S, Anta JL, Ferbeye L, Muñoz N, Franceschi S. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer 2001;85(1):46–54 http://dx.doi.org/10.1054/bjoc.2000.1825CrossrefGoogle Scholar

  • [6] Castellsagué X, Quintana MJ, Martínez MC, Nieto A, Sánchez MJ, Juan A, Monner A, Carrera M, Agudo A, Quer M, Muñoz N, Herrero R, Franceschi S, Bosch FX. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004;108(5):741–749 http://dx.doi.org/10.1002/ijc.11627CrossrefGoogle Scholar

  • [7] Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli M, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D. EUROCARE Working Group.EUROCARE-3: survival of cancer patients diagnosed 1990-94—results and commentary. Ann Oncol 2003;14(Suppl 5):v61–118 http://dx.doi.org/10.1093/annonc/mdg754CrossrefGoogle Scholar

  • [8] Smith EM, Rubenstein LM, Hoffman H, Haugen TH, Turek LP. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010;5:4 http://dx.doi.org/10.1186/1750-9378-5-4CrossrefGoogle Scholar

  • [9] Gudleviciene Z, Smailyte G, Pikelis A, Mickonas A. Prevalence of Human papillomavirus and other risk factors in Lithuanian head and neck cancer patients. Oncology 2009;76:205–208 http://dx.doi.org/10.1159/000201573CrossrefWeb of ScienceGoogle Scholar

  • [10] Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, Jensen MJ, Morgan GJ, Hughes CJ, Sutherland RL. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999;5:2810–2819 Google Scholar

  • [11] Ritchie JM, Smith EM, Summersgill KF, Hoffman T, Wang D, Klussmann JP, Turek LP, Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336–344 http://dx.doi.org/10.1002/ijc.10960CrossrefGoogle Scholar

  • [12] Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003;162:747–753 http://dx.doi.org/10.1016/S0002-9440(10)63871-0CrossrefGoogle Scholar

  • [13] Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, Turek LP. p16(INK4a) expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 2008;44:133–142 http://dx.doi.org/10.1016/j.oraloncology.2007.01.010CrossrefGoogle Scholar

  • [14] Geisler SA, Olshan AF, Weissler MC, Cai J, Funkhouser WK, Smith J, Vick K. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002;8:3445–3453 Google Scholar

  • [15] Smith EM, Wang D, Rubenstein LM, WA Morris, Turek LP, Haugen TH. Association between p53 and human papillomavirus in head and neck cancer curvival. Cancer Epidemiol Biomark Prev 2008;17:421–427 http://dx.doi.org/10.1158/1055-9965.EPI-07-2597CrossrefGoogle Scholar

  • [16] Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429–435 http://dx.doi.org/10.1056/NEJM199502163320704CrossrefGoogle Scholar

  • [17] Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997;14:811–818 http://dx.doi.org/10.1038/sj.onc.1200892CrossrefGoogle Scholar

  • [18] Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 2002;24:841–849 http://dx.doi.org/10.1002/hed.10146CrossrefGoogle Scholar

  • [19] Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–720 http://dx.doi.org/10.1093/jnci/92.9.709CrossrefGoogle Scholar

  • [20] Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–475 http://dx.doi.org/10.1158/1055-9965.EPI-04-0551CrossrefGoogle Scholar

  • [21] Geisler SA, Olshan AF, Weissler MC, et al. P16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002;8:3445–3453 Google Scholar

  • [22] Shin DM, Lee JS, Lippman SM, et al. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:519–529 http://dx.doi.org/10.1093/jnci/88.8.519CrossrefGoogle Scholar

  • [23] Couture C, Raybaud-Diogene H, Tetu B, et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 2002;94:713–722 http://dx.doi.org/10.1002/cncr.10232CrossrefGoogle Scholar

  • [24] Taylor D, Koch WM, Zahurak M, Shah K, Sidransky D, Westra WH. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol 1999;30:1221–1225 http://dx.doi.org/10.1016/S0046-8177(99)90041-2CrossrefGoogle Scholar

  • [25] Riethdorf S, Friedrich RE, Ostwald C, et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997;26:315–321 http://dx.doi.org/10.1111/j.1600-0714.1997.tb00222.xCrossrefGoogle Scholar

About the article

Published Online: 2012-03-29

Published in Print: 2012-06-01

Citation Information: Open Medicine, Volume 7, Issue 3, Pages 349–353, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-011-0148-4.

Export Citation

© 2012 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in